Pharmaceutical

Filter

Current filters:

None

Popular Filters

50 to 74 of 7210 results

NICE set to recommend Boehringer’s type 2 diabetes drug Jardiance

NICE set to recommend Boehringer’s type 2 diabetes drug Jardiance

22-01-2015

England’s health care costs watchdog the National Institute for Health and Care Excellence (NICE) has…

Boehringer IngelheimDiabetesJardiancePharmaceuticalPricingRegulationUK

EMA publishes guide for pharma companies to support new medicines monitoring standard

EMA publishes guide for pharma companies to support new medicines monitoring standard

22-01-2015

The European Medicines Agency has published its guide to support the implementation of a new international…

EMAEuropeEuropean Medicines AgencyPharmaceuticalRegulation

Moderate growth forecast for colorectal cancer drug market

22-01-2015

The value of the colorectal cancer (CRC) therapeutics market will increase moderately, from $8.3 billion…

AvastinBayerBristol-Myers SquibbErbituxGlobalMarkets & MarketingMerck KGaAOncologyPharmaceuticalRocheStivarga

Merck & Co drops marketing of hepatitis C drug Victrelis in USA

Merck & Co drops marketing of hepatitis C drug Victrelis in USA

22-01-2015

In an open letter to pharmacy professions, US pharma giant Merck & Co has advised that it is voluntarily…

Anti-viralsMarkets & MarketingMerck & CoPharmaceuticalUSAVictrelis

AstraZeneca files marketing authorization application with EMA for lesinurad

AstraZeneca files marketing authorization application with EMA for lesinurad

22-01-2015

The European Medicines Agency has accepted the marketing authorization application by AstraZeneca for…

AstraZenecaGastro-intestinalslesinuradPharmaceuticalRegulation

Ablynx successfully opposes Domantis' European patent appeal

Ablynx successfully opposes Domantis' European patent appeal

22-01-2015

Belgian drug developer Ablynx has successfully opposed the appeal lodged by Domantis over its European…

AblynxEuropeGSKLegalPharmaceutical

US and EU regulatory filings for UCB’s antiepileptic brivaracetam

US and EU regulatory filings for UCB’s antiepileptic brivaracetam

21-01-2015

Belgium’s largest pharma company UCB today announced regulatory filings in the USA and the European…

BRIVARACETAMEuropeNeurologicalPharmaceuticalRegulationUCBUSA

EMA launches public consultation on clinical trial transparency proposals

EMA launches public consultation on clinical trial transparency proposals

21-01-2015

The European Medicines Agency has launched a public consultation on how the transparency rules of the…

Clinical researchEuropeEuropean UnionPharmaceuticalRegulation

Supreme Court reverses Federal Circuit Court judgment on '808 patent in Teva's Copaxone

Supreme Court reverses Federal Circuit Court judgment on '808 patent in Teva's Copaxone

21-01-2015

The US Supreme Court has reversed the Federal Circuit Court’s judgment on Israel-based Teva Pharmaceutical…

CopaxoneLegalNeurologicalPharmaceuticalTevaUSA

Life sciences companies unprepared for whistleblower lawsuits, survey finds

Life sciences companies unprepared for whistleblower lawsuits, survey finds

21-01-2015

Although health care and life sciences companies are aware that they could be hit with federal “whistleblower”…

DissentFoley Hoag LLPLegalPharmaceuticalUSA

Report: Orphan drug prices facing increased scrutiny

Report: Orphan drug prices facing increased scrutiny

21-01-2015

With the US Food and Drug Administration approving an all-time record number of orphan drugs during 2014,…

PharmaceuticalPricingRare diseases

Salix reportedly pursing acquisition, pushed by shareholders

Salix reportedly pursing acquisition, pushed by shareholders

21-01-2015

USA-based Salix Pharmaceuticals is reportedly pursuing acquisition by a large drugmaker.

Mergers & AcquisitionsPharmaceuticalReutersSalix PharmaceuticalsUSA

US FTC approves final order preserving in nicotine patches market competition

US FTC approves final order preserving in nicotine patches market competition

21-01-2015

Following a public comment period, the USA’s Federal Trade Commission has approved a final order settling…

GlaxoSmithKlineHabitrolMergers & AcquisitionsNeurologicalNovartisPharmaceuticalRegulationUSA

Bristol-Myers to promote Caforio to CEO post; other appointments

Bristol-Myers to promote Caforio to CEO post; other appointments

21-01-2015

US pharma major Bristol-Myers Squibb yesterday announced a number of leadership changes approved by its…

BoardroomBristol-Myers SquibbManagementPharmaceuticalUSA

Novo Nordisk's Victoza granted label extension in the UK

Novo Nordisk's Victoza granted label extension in the UK

20-01-2015

A license extension has been granted in the UK for Victoza (liraglutide) from Danish insulin giant Novo…

Nephrology and HepatologyNovo NordiskPharmaceuticalRegulationUKVictoza

Johnson & Johnson beats profit forecasts, but group sales shy

Johnson & Johnson beats profit forecasts, but group sales shy

20-01-2015

US health care giant Johnson & Johnson has reported financial results for the fourth-quarter and full-year…

FinancialJohnson and JohnsonPharmaceutical

Ariad gets positive final EC decision on Iclusig

20-01-2015

USA-based Ariad Pharmaceuticals today revealed that the European Commission has endorsed the final opinion…

Ariad PharmaceuticalsEuropeIclusigOncologyPharmaceuticalRegulation

Tiziana licenses potential cancer therapy milciclib from Nerviano

Tiziana licenses potential cancer therapy milciclib from Nerviano

20-01-2015

Oncology and immunology specialist Tiziana Life Sciences has exclusively licensed milciclib from Nerviano…

LicensingmilciclibNerviano Medical SciencesOncologyPharmaceuticalResearchTiziana

Eisai launches epilepsy treatment Exalief in Russia

Eisai launches epilepsy treatment Exalief in Russia

20-01-2015

Japanese drug major Eisai has announced that epilepsy drug Exalief (eslicarbazepine acetate) will soon…

EisaiExaliefMarkets & MarketingNeurologicalPharmaceuticalRussia

FDA approves Fresenius Kabi’s neostigmine methylsulfate injection

FDA approves Fresenius Kabi’s neostigmine methylsulfate injection

20-01-2015

Fresenius Kabi, a unit of the Germany-headquartered Fresenius Group, has received approval from the US…

FreseniusFresenius Kabineostigmine methylsulfateNeurologicalPharmaceuticalRegulationUSA

PharmaEngine says positive Phase III results achieved with pancreatic cancer candidate MM-398

20-01-2015

Taiwan's PharmaEngine says that the additional analyses from the global Phase III NAPOLI-1 study of MM-398…

Merrimack PharmaceuticalsMM-398OncologyPharmaceuticalPharmaEngineResearch

Success of India-developed meningitis A vaccine MenAfriVac

Success of India-developed meningitis A vaccine MenAfriVac

20-01-2015

Meningitis A, that threatens the lives of 450 million people across 26 countries in Africa's ‘Meningitis…

HealthcareIndiaMenAfriVacPharmaceuticalSerum Institute of IndiaSub-Saharan AfricaVaccines

50 to 74 of 7210 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top